Recombinant luteinising hormone improves IVF in older women (NeLM, 20 March 2012)

Exciting new Open Access journal Endocrine Connections opens for submissions!

European Medicines Agency confirms positive benefit-risk balance of Protelos/Osseor, but recommends new contraindications and revised warnings (European Medicines Agency, Friday 16 March 2012)

19 Mar 2012

The European Medicines Agency has issued a new statement on the use of Protelos/Osseor in the treatment of osteoporosis in postmenopausal women.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read